OptimizeRx Corporation (OPRX) Balance Sheet
As of 2026-06-30 (10-Q), OptimizeRx Corporation (OPRX) reported total assets of $164.3M, total liabilities of $33.2M and shareholders' equity of $131.1M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $24.1M. Long-term debt: $19.7M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OPRXOptimizeRx CorporationFollow OPRX — free
—
Price chart with a free account
- Market cap
- 172.3M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.0 | 0.3 | 1.1 | 3.4 | 8.2 | 7.0 | 5.1 | 8.9 | 18.9 | 10.5 | 84.7 | 18.2 | 13.9 | 13.4 | 23.4 | 24.1 | |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | — | 55.9 | — | 0.0 | 0.0 | — | |
| Receivables | — | — | 1.5 | 2.1 | 2.8 | 2.0 | 3.4 | 6.5 | 7.4 | 17.9 | 24.8 | 22.2 | 36.3 | 38.2 | 37.8 | 24.8 | |
| Current assets | 1.6 | 1.0 | 2.6 | 5.6 | 11.1 | 10.2 | 8.8 | 15.7 | 27.1 | 32.9 | 115.1 | 98.6 | 54.3 | 54.0 | 64.7 | 54.1 | |
| Total assets | 2.9 | 2.2 | 4.0 | 7.0 | 12.3 | 11.5 | 9.8 | 25.1 | 56.6 | 60.3 | 141.0 | 134.7 | 183.4 | 171.2 | 176.9 | 164.3 | |
| Current liabilities | 1.3 | 0.8 | 2.3 | 2.4 | 3.4 | 3.7 | 3.5 | 4.2 | 6.1 | 10.0 | 9.4 | 8.4 | 17.9 | 18.7 | 21.3 | 9.7 | |
| Long-term debt | 0.0 | — | — | — | — | — | — | — | — | — | — | — | 38.3 | 34.3 | 26.3 | 19.7 | |
| Short-term debt | — | — | — | — | — | — | — | — | — | — | — | — | 2.0 | 2.0 | 4.3 | 1.3 | |
| Total liabilities | 1.3 | — | — | — | — | — | 3.5 | 6.6 | 11.8 | 10.4 | 9.6 | 8.5 | 56.8 | 54.2 | 48.6 | 33.2 | |
| Shareholders' equity | 1.6 | 1.4 | 1.7 | 4.6 | 8.9 | 7.8 | 6.2 | 18.5 | 44.9 | 50.0 | 131.4 | 126.1 | 126.6 | 117.0 | 128.3 | 131.1 |
USD millions · SEC XBRL
OptimizeRx Corporation — questions
- How much cash does OptimizeRx Corporation have?
- $24.1M in cash and cash equivalents as of 2026-06-30.
- How much debt does OptimizeRx Corporation have?
- $19.7M of long-term debt and $1.3M due within a year as of 2026-06-30.
- What are OptimizeRx Corporation's total assets?
- $164.3M as of 2026-06-30.
- What is OptimizeRx Corporation's shareholders' equity?
- $131.1M as of 2026-06-30.
Every figure on this page comes from OptimizeRx Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.